Connection
Kenneth Tyler to Natalizumab
This is a "connection" page, showing publications Kenneth Tyler has written about Natalizumab.
|
|
Connection Strength |
|
|
|
|
|
0.882 |
|
|
|
-
Tyler KL, Vollmer TL. To PLEX or not to PLEX in natalizumab-associated PML. Neurology. 2017 03 21; 88(12):1108-1109.
Score: 0.581
-
Clifford DB, Tyler KL. Dosing interval of natalizumab in MS: Do good things come to those who wait? Neurology. 2019 10 08; 93(15):655-656.
Score: 0.173
-
Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005 Jul 28; 353(4):369-74.
Score: 0.065
-
Tyler KL, Khalili K. Natalizumab and progressive multifocal leukoencephalopathy: highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA. Rev Neurol Dis. 2005; 2(3):144-9.
Score: 0.063